{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:02:18Z","timestamp":1781067738658,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NARSAD Young Investigator Award"},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["MOP 89853"],"award-info":[{"award-number":["MOP 89853"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"OMHF"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.pnpbp.2012.03.001","type":"journal-article","created":{"date-parts":[[2012,3,8]],"date-time":"2012-03-08T15:11:48Z","timestamp":1331219508000},"page":"134-141","source":"Crossref","is-referenced-by-count":67,"title":["Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain"],"prefix":"10.1016","volume":"38","author":[{"given":"E.J.","family":"Brandl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Frydrychowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.P.","family":"Lett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Kitzrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"B\u00fcttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ehrlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.Y.","family":"Meltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Puls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2012.03.001_bb0005","doi-asserted-by":"crossref","first-page":"e22662","DOI":"10.1371\/journal.pone.0022662","article-title":"A double blind, placebo-controlled, randomized crossover study of the acute metabolic effects of olanzapine in healthy volunteers","volume":"6","author":"Albaugh","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0010","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(02)11706-5","article-title":"759C\/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain","volume":"360","author":"Basile","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/YPG.0b013e3283328e06","article-title":"Leptin gene -2548G\/A variants predict risperidone-associated weight gain in children and adolescents","volume":"19","author":"Calarge","year":"2009","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0025","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1093\/bioinformatics\/btq352","article-title":"mbmdr: an R package for exploring gene\u2013gene interactions associated with binary or quantitative traits","volume":"26","author":"Calle","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/mgme.2000.3015","article-title":"Molecular heterosis: a review","volume":"71","author":"Comings","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1461145707007547","article-title":"Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis","volume":"10","author":"De Luca","year":"2007","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hup.868","article-title":"HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis","volume":"22","author":"De Luca","year":"2007","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gepi.10252","article-title":"Pedigree disequilibrium tests for multilocus haplotypes","volume":"25","author":"Dudbridge","year":"2003","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000119108","article-title":"Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data","volume":"66","author":"Dudbridge","year":"2008","journal-title":"Hum Hered"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.pnpbp.2009.03.007","article-title":"The role of leptin and cortisol in hyperactivity in patients with acute and weight-recovered anorexia nervosa","volume":"33","author":"Ehrlich","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0060","first-page":"57","article-title":"Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia","volume":"40","author":"Ellingrod","year":"2007","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000115333","article-title":"Monogenic human obesity","volume":"36","author":"Farooqi","year":"2008","journal-title":"Front Horm Res"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2010.06.001","article-title":"Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin","volume":"121","author":"Fernandez","year":"2010","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0075","author":"Gauderman"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2710.2009.01084.x","article-title":"Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair study","volume":"35","author":"Gebhardt","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JCP.0b013e31819359be","article-title":"Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication","volume":"29","author":"Gregoor","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0085","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/JCP.0b013e3181fa05a2","article-title":"Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medication","volume":"30","author":"Gregoor","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/YPG.0b013e32833b6378","article-title":"Association between LEP and LEPR gene polymorphisms and dyslipidemia in patients using atypical antipsychotic medication","volume":"20","author":"Gregoor","year":"2010","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0095","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2217\/pgs.11.40","article-title":"Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic setting","volume":"12","author":"Gregoor","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1055\/s-2002-33466","article-title":"A polymorphism in the leptin promoter region (\u22122548 G\/A) influences gene expression and adipose tissue secretion of leptin","volume":"34","author":"Hoffstedt","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pnpbp.2007.08.002","article-title":"Possible association between the -2548A\/G polymorphism of the leptin gene and olanzapine-induced weight gain","volume":"32","author":"Kang","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0115","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"From the cover: antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0120","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/JCP.0b013e318234ee84","article-title":"Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients","volume":"31","author":"Kuo","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0125","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0130","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2217\/pgs.11.45","article-title":"Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications","volume":"12","author":"Lee","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/mp.2011.109","article-title":"Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications","volume":"17","author":"Lett","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0140","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/512133","article-title":"No gene is an island: the flip-flop phenomenon","volume":"80","author":"Lin","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.schres.2010.10.008","article-title":"Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs","volume":"125","author":"Moons","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0150","first-page":"316","article-title":"\u22122548G\/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association","volume":"33","author":"Mou","year":"2008","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0160","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/14622416.7.6.863","article-title":"Genetics of antipsychotic treatment emergent weight gain in schizophrenia","volume":"7","author":"Muller","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0155","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.euroneuro.2005.02.001","article-title":"Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia","volume":"15","author":"Muller","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2004.12.037","article-title":"The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia","volume":"379","author":"Muller","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2217\/pgs.10.50","article-title":"Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample","volume":"11","author":"Opgen-Rhein","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0175","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/JCP.0b013e3181fae248","article-title":"Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment","volume":"30","author":"Perez-Iglesias","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4088\/JCP.v63n1206","article-title":"Predictors of noncompliance in patients with schizophrenia","volume":"63","author":"Perkins","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0190","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0140-6736(02)08913-4","article-title":"Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism","volume":"359","author":"Reynolds","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0185","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.pnpbp.2005.03.019","article-title":"The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment","volume":"29","author":"Reynolds","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0195","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/sj.mp.4001944","article-title":"Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients","volume":"12","author":"Ruano","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0200","first-page":"423","article-title":"Association study of -2548A\/G polymorphism of leptin gene with antipsychotics-induced weight gain","volume":"17","author":"Ryu","year":"2006","journal-title":"Korean J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0215","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi","year":"2008","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0220","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/JCP.0b013e3181a390ed","article-title":"Ghrelin and leptin levels in schizophrenic patients treated with antipsychotic monotherapy","volume":"29","author":"Sentissi","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0225","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/14622416.9.8.1055","article-title":"Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes","volume":"9","author":"Srivastava","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01213011-200504000-00002","article-title":"Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis","volume":"15","author":"Templeman","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0235","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00041444-200512000-00011","article-title":"Clozapine-induced weight gain: a study in monozygotic twins and same-sex sib pairs","volume":"15","author":"Theisen","year":"2005","journal-title":"Psychiatr Genet"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0240","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.pnpbp.2010.08.009","article-title":"Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients","volume":"34","author":"Tiwari","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0245","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/npp.2009.235","article-title":"A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia","volume":"35","author":"Tiwari","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000122267","article-title":"Increased plasma leptin in antipsychotic-naive females with schizophrenia, but not in males","volume":"56","author":"Wang","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0255","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.psychres.2004.02.018","article-title":"Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation","volume":"133","author":"Wehmeier","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(02)00498-X","article-title":"Obesity as a risk factor for antipsychotic noncompliance","volume":"66","author":"Weiden","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0265","first-page":"720","article-title":"Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study","volume":"36","author":"Wu","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0270","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1192\/bjp.bp.107.041723","article-title":"Influence of 5-HT2C receptor and leptin gene polymorphisms, smoking and drug treatment on metabolic disturbances in patients with schizophrenia","volume":"192","author":"Yevtushenko","year":"2008","journal-title":"Br J Psychiatry: J Ment Sci"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0280","first-page":"2119","article-title":"Association of -2548G\/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain","volume":"83","author":"Zhang","year":"2003","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.pnpbp.2012.03.001_bb0275","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/jcp.0b013e3180582412","article-title":"Association of clozapine-induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population","volume":"27","author":"Zhang","year":"2007","journal-title":"J Clin Psychopharmacol"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584612000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T23:52:44Z","timestamp":1687305164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584612000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0278584612000474"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.03.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}